February 5, 2020
Zeria Pharmaceutical and Kyowa Kirin said on February 3 that they will wind up their marketing collaboration for the ulcerative colitis treatment Asacol (mesalazine) at the end of March upon the expiration of their current agreement. Zeria, the marketing authorization...read more